Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/NVO
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Novo Nordisk A/S (NVO) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Novo Nordisk (NVO) trades at $39.22, up 3.05% with strong earnings momentum after beating Q2 2026 EPS estimates. The stock shows bearish technical signals but maintains robust fundamentals with 35.35% net margins and 59.82% ROE. Recent news highlights pipeline developments including Wegovy pill data and FDA review extensions for hemophilia treatments.
NVO presents a mixed outlook with strong profitability and analyst consensus ($42.33 target) offset by technical weakness and competitive pressures. Investment appeal lies in GLP-1 market leadership, though risks include regulatory delays and Eli Lilly competition. Current valuation at 9.32 P/E offers reasonable entry for growth exposure.
Read full analysis

Key Stats

  • Market Cap
    $169.24B
  • Volume
    9,314,273
  • Sector
    Health
  • 52W High
    $63.98
  • 52W Low
    $35.29
  • Typical Hold Time
    116 Days
  • Enterprise Value
    $187.94B
  • Div Yield
    4.71%
  • Trading Activity
    53% Sell | 47% Buy
$39.28
52W Low: $35.29
30 Mar 2026
52W High: $63.98
26 Jan 2026

Track Novo Nordisk A/S (NVO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Novo Nordisk A/S has traded between a low of $35.29 and a high of $63.98, highlighting its annual price range. Buy and sell Novo Nordisk A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Most Recent News

Content is generated by Aura AI

UBS Group AG surpasses 5% ownership in Bang & Olufsen shares as of October 9, 2026

UBS Group AG has officially notified that it holds 7,768,727 shares in Bang & Olufsen A/S, representing 5.27% of the company's total share capital and voting rights as of October 9, 2026. This disclosure is made in compliance with the Danish Capital ...

Market News
1 hour ago
Na
Neutral
UBS Group AG surpasses 5% ownership in Bang & Olufsen shares as of October 9, 2026

FDA approves Roche’s Enspryng as first at-home treatment for thyroid eye disease

The FDA has approved Roche's Enspryng (satralizumab) as the first and only at-home subcutaneous treatment for adults with thyroid eye disease (TED). This approval follows positive results from Phase III SatraGO-2 trials showing significant reductions...

Market News
3 hours ago
Roche
Bullish
news icon
FDA approves Roche’s Enspryng as first at-home treatment for thyroid eye disease

Oil tightens as US crude stocks drop and Gulf shipping risks rise amid sanction talks.

US crude oil inventories fell sharply by 8.6 million barrels, tightening the oil market as refiners run near full capacity. The US government considers easing tanker sanctions to lower shipping costs, but insurers remain cautious due to EU and UK rul...

Market News
4 hours ago
FXEmpire
Neutral
Oil tightens as US crude stocks drop and Gulf shipping risks rise amid sanction talks.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $169.24B
  • Volume
    9,314,273
  • Sector
    Health
  • 52W High
    $63.98
  • 52W Low
    $35.29
  • Typical Hold Time
    116 Days
  • Enterprise Value
    $187.94B
  • Div Yield
    4.71%
  • Trading Activity
    53% Sell | 47% Buy
$39.28
52W Low: $35.29
30 Mar 2026
52W High: $63.98
26 Jan 2026

Track Novo Nordisk A/S (NVO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Novo Nordisk A/S has traded between a low of $35.29 and a high of $63.98, highlighting its annual price range. Buy and sell Novo Nordisk A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!